Inactive Instrument

Instituto Hermes Pardini S.A. Stock

Equities

PARD3

BRPARDACNOR1

Healthcare Facilities & Services

Dynamic Chart
Instituto Hermes Pardini S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from S&P Global BMI Index CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from Brazil Small Cap Index CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from Brazil Special Corporate Governance Stock Index CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from Brazil Special Tag Along Stock Index CI
Fleury S.A. completed the acquisition of Instituto Hermes Pardini S.A. from Pardini family and others. CI
Transcript : Instituto Hermes Pardini S.A., Q4 2022 Earnings Call, Mar 15, 2023
Instituto Hermes Pardini S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Instituto Hermes Pardini S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Instituto Hermes Pardini S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Instituto Hermes Pardini Seeks Acquisitions CI
Transcript : Instituto Hermes Pardini S.A., Q3 2022 Earnings Call, Nov 11, 2022
Instituto Hermes Pardini S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Instituto Hermes Pardini S.A. acquired Laboratório Hugo Silviano Brando for BRL 11 million. CI
Instituto Hermes Pardini S.A. agreed to acquire Laboratório Hugo Silviano Brando for BRL 11 million. CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 02-12-31
Director of Finance/CFO 63 23-05-30
Chief Operating Officer 47 10-02-28
Members of the board TitleAgeSince
Director of Finance/CFO 63 23-05-30
Chairman 54 23-05-25
Director/Board Member 48 23-05-25
More insiders
Instituto Hermes Pardini SA is a Brazil-based company engaged in the management of medical laboratories. The Company provides various diagnostic and analytical services, including toxicological examination, clinical blood analysis, veterinary test, cryopreservation, diagnostic imaging, vaccination, deoxyribonucleic acid (DNA) screening test, as well as cardiometabolic examination, among others. The Company operates a number of healthcare units in the states of Minas Gerais and Sao Paulo, Brazil. The Company belongs to the Hermes Pardini Group.
More about the company